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Abstract
Background: Reduced health-related quality of life in the physical domain (HRQOLphysical) has been reported to
increase risks for cardiovascular disease (CVD); however, the mechanism underlying this phenomenon is still unclear.
The autonomic nervous system (ANS) that connects the body and mind is a biologically plausible candidate to
investigate this mechanism. The aim of our study is to examine whether the HRQOLphysical independently
contributes to heart rate variability (HRV), which reflects ANS activity.
Methods: We recruited 329 physically and mentally healthy adults. All participants completed Beck Anxiety Inventory,
Beck Depression Inventory and World Health Organization Questionnaire on Quality of Life: Short Form-Taiwanese
version (WHOQOL-BREF). They were divided into groups of individuals having high or low scores of HRQOLphysical as
discriminated by the quartile value of WHOQOL-BREF. We obtained the time and frequency-domain indices of HRV,
namely variance (total HRV), the low-frequency power (LF; 0.05–0.15 Hz), which may reflect baroreflex function, the
high-frequency power (HF; 0.15–0.40 Hz), which reflects cardiac parasympathetic activity, and the LF/HF ratio.
Results: There was an independent contribution of HRQOLphysical to explaining the variance in HRV after excluding
potential confounding factors (gender, age, physical activity, alcohol use, depression and anxiety). Compared with the
participants with high levels of HRQOLphysical, those with low levels of HRQOLphysical displayed significant reductions in
variance and LF.
Conclusions: This study highlights the independent role of low HRQOLphysical in contributing to the reduced HRV in
healthy adults and points to a potential underlying mechanism for HRQOLphysical to confer increased risks for CVD.
Keywords: Quality of life, Cardiovascular disease, Autonomic nervous system
Background
Health-related quality of life (HRQOL) is becoming in-
creasingly used for evaluating health services in clinical
practice [1]. The World Health Organization has defined
the HRQOL as an individual’s view of himself or herself
in terms of his/her hopes, objectives, values, and worries
[2]. The HRQOL reflects both an individual’s physical
and psychological health. Aside from this, the HRQOL
also reflects an individual’s social status and the quality
of his/her surrounding environment. All in all, an indi-
vidual’s physical health, psychological health, social sta-
tus, and the quality of his/her surrounding environment,
can all influence an individual’s well-being.
A growing body of research indicates that people who re-
port lower HRQOL have higher all-cause mortality [3–6].
Some researchers have shifted the focus of their HRQOL
research to its relationship with specific disease incidence
and disease outcomes to increase the understanding of why
this association exists. For example, some research teams
first explored whether lower HRQOL is a risk factor for
cardiovascular disease (CVD). As a follow up inquisition,
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hypothesis proved to be true, which realms of the HRQOL
acts as a predictor of CVD. As they have anticipated, the re-
sults of their studies have shown that impaired HRQOL
was related to high prevalence of overt CVD [7] and subse-
quent CVD incidence [8–10]. In addition, they all ap-
proved that impaired HRQOL in the physical domain
(HRQOLphysical) may increase CVD risks independently of
traditional CVD risk factors. However, the mechanisms
associated with the link between this novel risk factor and
CVD are yet to be established.
The score of the HRQOLphysical is rated by the partici-
pant intuitively. Thus, HRQOLphysical reflects the bodily
physiological health determined by certain factors per-
ceived by the individual. This process of perception re-
lies on an integral body-mind connection. When mind–
body dissonance or disconnection [11] occurs, partici-
pants might report an unrealistically high HRQOLphysical
to the investigators though they in fact had poor physical
conditions [12]. In humans, the autonomic nervous
system (ANS) plays important roles in flexibly adjust-
ing the response of the body to a range of environ-
mental demands and internal stimuli [13, 14]. A
series of past studies have shown altered ANS activity
among subjects with psychosomatic symptoms, which
include anxiety [15], depression [16] and chronic fa-
tigue syndrome [17]. All these findings support the
idea that the ANS activity reflects the interaction be-
tween mind and body. So far various techniques have
been developed to detect the ANS activity. In the last
two decades, short-term frequency-domain analysis of
heart rate variability has been developed as a sophisti-
cated and non-invasive tool for detecting ANS activity
[18]. Heart rate variability (HRV) refers to the com-
plex beat-to-beat variation in heart rate measured by
electrocardiogram. Variability in heart rate is pro-
duced by the sympathetic nerves, which accelerate
heart rate, and the parasympathetic (vagus) nerves,
which decelerate it. An increased level of HRV re-
flects a healthy ANS that is able to respond to envir-
onmental demands [13]. Individuals with higher levels
of resting HRV have been shown to have greater abil-
ities of emotion regulation [19]. In contrast, low HRV
is an indicator of autonomic inflexibility [20] and a
predictor of poor health status [21]. In the cardiovas-
cular territory, a high degree of HRV aids healthy car-
diac activity and provides a protective effect against
myocardial infarction and heart failure [22], whereas
decreased parasympathetic tone [23] is associated with an
increased risk of CVD and mortality. All in all, HRV is a
biologically plausible candidate for investigating the mech-
anisms underlying the contribution of HRQOLphysical to
CVD risks. This in turn prompts us to raise the important
question of whether there is an association between
HRQOLphysical and HRV.
Most studies supporting an association existing be-
tween the HRQOL and HRV have been conducted in
clinical samples with chronic illness [24–26]. The
physiologic consequences of chronic illness could influ-
ence the relationship observed between HRQOL and
HRV. Few studies have focused on healthy individuals in
order to avoid overestimation of the association between
HRQOL and HRV, but these studies’ results were incon-
sistent [11, 27, 28]. Furthermore, these studies have the
limitation of lacking a procedure to control the physical
and psychiatric conditions that can confound HRV
profiles. Overall, these studies have only tried to
prove whether HRV predicts HRQOL. To the extent
of our knowledge, no study has examined whether
HRQOLphysical and/or other domains independently
affect the HRV profiles in healthy individuals.
Aims of the study
The present study aimed to test the following hypoth-
eses: (a) there is a meaningful correlation between the
HRQOLphysical and HRV; (b) in healthy subjects, the
HRQOLphysical can independently contribute to HRV;
and (c) the subjects with low levels of HRQOLphysical




The study was approved by the local Ethics Committee
TSGHIRB-099-05-171 and 2-101-05-049. Participants
were informed that their clinical details in the study
would be published. Written informed consent was ob-
tained from all participants and made available to the
Editor upon request. After detailed questionnaire
screening, chart review, clinical examination, electro-
cardiography, and relevant laboratory investigations,
the subjects who were pregnant or had cancer, pos-
tural hypotension, vasovagal syncope, cardiovascular,
respiratory, neurological, or endocrinological disorders
that affect HRV, or those engaged in regular and
strenuous physical training, were excluded. Current or
past smokers were also excluded. All participants were
drug-naïve or had not used any medications that have
been reported to affect autonomic functioning (e.g., anti-
psychotics, anticholinergics, antidepressants, oral contra-
ceptives, anticonvulsants, anxiolytics, cerebral metabolic
activators, or cerebral vasodilators) for at least 1 month
prior to the beginning of the study. Each participant was
evaluated using the Chinese version of the Modified
Schedule of Affective Disorder and Schizophrenia-
Lifetime (SADSL) [29] to exclude those with psychiatric
conditions. A total of 329 healthy volunteers with valid
data on both self-reported questionnaires and HRV were
included in the final statistical analysis.
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Control variables
Previous findings have revealed that gender, age, body
mass index (BMI), physical activity, and alcohol use are
among the factors significantly affecting the autonomic
control of heart rate [30–32]. These factors were thus
selected as control variables. Subjects reported their
average frequency of physical exercise per week (A) and
the hours per session spent in purposeful exercise (B) in
the past 6 months. “A” was rated with a five-point scale
according to the frequency of exercise involving heavy
breathing and sweating as “never”, “seldom”, “once a
week”, “twice a week”, and “more than twice a week”
[31]. The participants’ self-reported weekly habitual
physical activity was calculated by the formula: A × B.
Alcohol use, assessed with two items of the Alcohol Use
Disorder Identification Test questionnaire [33], was de-
fined by the average frequency of drinking and the num-
ber of drinks consumed on a typical drinking day in the
past year. From these items, we derived the average
amount of alcoholic drinks per day, with one drink de-
fined as a standard drink, i.e., having the equivalent of
10 g of alcohol [34].
Psychological variables: assessment of anxiety/depression
severity
Since depression [16] and anxiety [15] can profoundly
influence HRV measures, all participants completed the
Beck Depression Inventory (BDI) and Beck Anxiety
Inventory (BAI). BDI is a 21-item questionnaire that as-
sesses the subjects’ self-reported severity of depression
[35]. Its Chinese version has a substantial internal
consistency and reliability [36]. The results are scored by
summing the responses to all of the items in order to
obtain a total depression score (range, 0–63). The BAI
contains 21 items that measure anxiety-related symp-
toms [37]. Its Chinese version has good test-retest reli-
ability and fair concurrent validity [38]. Subjects were
asked to rate the severity of their anxiety on 4-point
Likert scales (0–3). The total scores of BAI range from 0
to 63.
Measuring health-related quality of life
HRQOL was assessed with the self-administered World
Health Organization Questionnaire on Quality of Life:
Short Form-Taiwanese version (WHOQOL-BREF) which
was developed by the WHO to evaluate HRQOL [2] and
was adapted to Taiwan’s unique culture by Yao et al.
[39]. The questionnaire contained 28 five-point items
that assessed general (two items) and four specific do-
mains of HRQOL, including seven items in physical
health, six in psychological, four in social relationships,
and nine in environmental domains, with well-
established validity and reliability [39]. The domain
scores were calculated by multiplying the mean of all
item scores by a factor of four. Thus, the scores ranged
from 4 to 20, with higher scores indicating better
HRQOL.
Measurements of blood pressure, respiratory rate and
heart rate variability
Blood pressure (BP) was recorded with a Tensoval duo
control Digital Blood Pressure Monitor (HARTMANN
AG, Heidenheim, Germany). Systolic BP (SBP) and dia-
stolic BP (DBP) were measured twice from the right arm
during supine rest and then averaged. The participants’
respiration was recorded by using the Thought Technology
Infiniti system (See also http://thoughttechnology.com/)
according to the recommended procedures. An elastic
band of the respirometer was adjusted to a snug, but with
a comfortable tightness around participants’ upper abdo-
men. At the end of the session the recordings were coded
and saved for subsequent analysis. Movement artifacts
were automatically removed by the Infiniti software from
the session overview which provides a display of the total
session of respiration data. The detailed procedures for the
analysis of HRV were as reported in our previous studies
[40, 41]. After 20 min of supine rest, a lead I electrocardio-
gram was taken for 5 min in the daytime while each sub-
ject lay quietly in a soundproof, light-controlled recording
room and spontaneously breathed. Electrodes were placed
on the right and left arm (Einthoven’s Triangle Lead I) just
below the elbow with a ground electrode placed below the
wrist on the right arm. An HRV analyzer (SSIC, Enjoy
Research Inc., Taipei, Taiwan) acquired, stored, and proc-
essed the electrocardiography signals. Our computer algo-
rithm then identified each QRS complex and rejected each
ventricular premature complex or noise according to its
likelihood in a standard QRS template [41]. Signals were
recorded at a sampling rate of 512 Hz, using an 8-bit
analogue-to-digital converter. Stationary R-R interval
values were re-sampled and interpolated at a rate of
7.11 Hz to produce continuity in the time domain. The
power spectral analysis was performed using a non-
parametric fast Fourier transformation. The direct current
component was deleted, and a Hamming window was used
to attenuate the leakage effect [40]. The power spectrum
was subsequently quantified into standard frequency-
domain measurements, namely variance (variance of R-R-
interval values), very low-frequency power (VLF, 0.003–
0.04 Hz), low-frequency power (LF, 0.04–0.15 Hz),
high-frequency power (HF, 0.15–0.40 Hz), and the ra-
tio of LF to HF power (LF/HF). All of the measure-
ments were logarithmically transformed to correct for
a skewed distribution [42].
Vagal control of HRV is represented by HF, whereas
both vagal and sympathetic control of HRV are jointly
represented by LF. The LF also reflects baroreflex func-
tion during supine rest [43]. The LF/HF ratio could
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mirror sympatho-vagal balance or sympathetic modu-
lation, with a larger LF/HF ratio indicating a greater
predominance of sympathetic activity over cardiac
vagal control. The VLF component has been attrib-
uted variously to thermoregulatory processes, periph-
eral vasomotor activity, and the renin-angiotensin
system; however, its definite physiological meaning is
under debate [44].
Statistical analyses
SPSS version 19.0 (SPSS Inc. Chicago, USA) statistical
software was used for all analyses. All HRQOL,
physiological, psychological and control variables in
the present study were checked for deviations from the
Gaussian distribution using the Kolmogorov–Smirnov
test. Pearson’s and Spearman’s correlations coefficients
were used to analyze the correlations between parametric
and non-parametric continuous variables, respectively.
Hierarchical regression analyses were used to explore the
effect of HRQOL on HRV profiles after adjusting for psy-
chological states (depression and anxiety) and control var-
iables. The psychological states and control variables
relating to HRV in univariate analysis (p < 0.05) were en-
tered into step 1 of the hierarchical regression analysis,
while mean R-R intervals and HRV indices were the
dependent variables. Data including R2, R2-changes, F,
standardization regression coefficient (β),and p value, in
the regression model are presented. Tolerance and
variance inflation factors were used to check for mul-
ticollinearity. In addition, participants were divided
into two groups by their scores of HRQOLphysical. We
took the highest quartile as the point of dichotomiz-
ing HRQOLphysical. The selection of the cut-off points
in the present study was done through applying the
categorization method using quartile values. Independent-
samples t-tests were conducted to determine between-
group differences in demographics and control variables.
A multivariate analysis of variance (MANOVA) was
performed to determine whether there were between-
group differences on an interpretable composite of
HRV variables across time and frequency-domain, and
to provide a control for multiple comparisons. Ana-
lysis of covariance adjusted for any significant differ-
ences in the baseline characteristics known to affect
cardiac measures. A significant Pillai’s trace effect for
group was followed by univariate analyses of variance
(ANOVAs) to identify which measures contributed to
a significant multivariate effect. Findings were corrected
for multiple comparisons via Bonferroni correction. Eta-
squared (η2) was reported for ANOVA effects as an
indicator of effect size (small = 0.01 medium = 0.06,
large = 0.14). The statistical analysis was conducted at




The participants ranged in age from 20 to 54 years, with
a mean age of 36.91 ± 11.37 years. The mean education
level was 12.59 ± 3.23 years, the mean exercise level was
1.27 ± 2.17 h/week and 55.3 % were female. The mean
BMI was 21.88 ± 2.44 kg/m2 and 32 (9.7 %) of our sample
were underweight, 281 (85.4) % were of normal weight
and 16 (4.9 %) were overweight. The mean SBP and mean
DBP were 115.91 ± 12.80 and 72.72 ± 7.18 mmHg respect-
ively. The mean alcohol use was 0.01 ± 0.02 drinks/day.
The scores from the WHOQOL-BREF Taiwanese version,
BDI, and BAI are presented in Table 1.
Factors associated with HRV profiles
Analysis of associations between HRV indices and po-
tential moderators were shown in Table 2. Men had
significantly higher LF than women. Older partici-
pants had reduced variance (total HRV), VLF, LF and
HF. Participants with higher SBP had increased VLF.
The BAI score was associated with reduced variance
and LF. The physical domain scores of WHOQOL-
BREF (HRQOLphysical) positively correlated with the
variance, VLF, LF, and HF. The remaining variables
showed no significant association with HRV indices.
Independent effects of HRQOLphysical on resting HRV
profiles
After adjusting for control variables and psychological
states (BDI and BAI scores), the HRQOLphysical scores
were still associated with increased variance, VLF, LF,
and HF (Table 3). Tolerance (range: 0.849–0.995) and
variance inflation (range: 1.005–1.178) did not indicate
multicollinearity.
Heart rate variability parameters: High HRQOLphysical
group versus low HRQOLphysical group
The highest quartile value of the HRQOLphysical scores
of the 329 participants was 12.0. The mean breathing
rate was 13.91 ± 3.37 breaths/min for the subjects with
HRQOLphysical scores above the upper quartile (high
HRQOLphysical group) and 13.70 ± 3.15 breaths/min for
those with HRQOLphysical scores below the upper
quartile (low HRQOLphysical group). The breathing rate
was not significantly different between the two groups
(p = 0.58). The high HRQOLphysical group had a less per-
centage of female participants, a lower age, BDI scores,
and BAI scores but more physical activity as compared to
the low HRQOLphysical group (Table 4). The MANOVA
comparing the various HRV measures between high
HRQOLphysical and low HRQOLphysical groups showed sig-
nificant results [F (6, 322) = 9.67, p < 0.001, η2 = 0.153].
The result did not significantly alter after adjusting for
gender, age, physical activity, BDI scores, and BAI scores
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[F (6, 317) = 5.40, p < 0.001, η2 = 0.093]. A separate
ANOVA was conducted for each dependent variable,
with each ANOVA evaluated at an alpha level of
0.0083 (0.05/6). Compared with the high HRQOLphysical
group, the low HRQOLphysical group displayed signifi-
cant reductions in variance [F (1322) = 18.09, p < 0.001,
η2 = 0.053; Fig. 1], VLF [F (1322) = 12.41, p < 0.001,
η2 = 0.037], and LF [F (1322) = 9.61, p = 0.002, η2 = 0.029].
However, the groups did not significantly differ on mean
R-R intervals [F (1322) = 2.16, p = 0.14, η2 = 0.0007],
HF [F (1322) = 1.91, p = 0.17, η2 = 0.006], or LF/HF
ratio [F (1322) = 3.89, p = 0.049, η2 = 0.012].
Table 1 Sample characteristics
Clinical and demographic data Number Percent Mean ± SD Range
Males 147 44.70
Females 182 55.30
Age, years 329 36.91 ± 11.37 20.00–54.00
Education, years 329 12.59 ± 3.23 6.00–22.00
BMI, kg/m2 329 21.88 ± 2.44 17.04–26.90
Weekly regular exercise, hours 329 1.27 ± 2.17 0.00–9.50
Alcohol use, drinks/day 329 0.01 ± 0.02 0.00–0.15
SBP, mmHg 329 115.91 ± 12.80 80.00–138.00
DBP, mmHg 329 72.72 ± 7.18 55.00–88.00
BDI scores 329 5.60 ± 3.71 0.00–12.00
BAI scores 329 7.85 ± 2.73 1.00–12.00
WHOQOL-BREF Taiwan version
Scores of physical health domain 329 11.57 ± 2.04 4.00–20.00
Scores of psychological domain 329 13.07 ± 2.01 6.67–19.33
Scores of social relationships domain 329 14.60 ± 3.04 8.00–20.00
Scores of environmental domain 329 14.57 ± 2.68 5.33–19.11
Abbreviations: SD standard deviation, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index (calculated as weight in kilograms divided by
height in meters squared), BDI Beck Depression Inventory, BAI Beck Anxiety Inventory, WHOQOL-BREF World Health Organization Questionnaire on Quality of Life:
Short Form-Taiwan version
Table 2 Factors associated with resting HRV indices among all participants
Mean RR intervals Var VLF LF HF LF/HF
Sex(women/men)a 0.07 0.18 0.06 0.24* 0.18 0.07
Ageb 0.02 −0.45* −0.31* −0.45* −0.50* 0.15
BMIb 0.08 0.09 0.07 0.09 0.05 0.06
Physical activityb 0.07 0.14 0.09 0.15 0.12 0.09
Alcohol useb 0.02 −0.06 −0.08 −0.12 −0.05 −0.08
SBPb −0.01 −0.02 0.21* 0.00 0.01 −0.01
DBPb 0.03 0.04 0.10 0.03 0.05 −0.03
BDI scoresb −0.15 −0.14 −0.15 0.05 −0.17 0.15
BAI scoresb −0.09 −0.19* −0.02 −0.22* −0.15 −0.07
WHOQOL-BREF Taiwan version
Scores of physical health domainb 0.16 0.44* 0.37* 0.35* 0.30* 0.03
Scores of psychological domainb −0.01 0.12 0.15 0.08 0.08 −0.02
Scores of social relationships domainb 0.05 0.11 0.12 0.12 0.04 0.06
Scores of environmental domainb 0.04 0.05 0.05 −0.00 −0.01 0.02
Abbreviations: BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, Var total variance [ln(ms2)], VLF, very low-frequency power [ln(ms2)],
LF low frequency power [ln(ms2)], HF high frequency power [ln(ms2)], LF/HF ratio of LF to HF [ln(ratio)], BDI Beck Depression Inventory; BAI Beck Anxiety Inventory,
WHOQOL-BREF World Health Organization Questionnaire on Quality of Life: Short Form-Taiwan version
aPoint-biserial correlations; first category in parenthesis is the reference group
bProduct-moment correlations
* p < 0.00064; with a Bonferroni correction, only correlations with p < 0.00064 were considered significant
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Discussion
Numerous studies have stressed that ANS activity has
significant impact on HRQOL among patient popula-
tion, mainly because altered ANS activity is a fre-
quent physiological consequence of the diseases,
thereby relating ANS activity to patient perceptions of
HRQOL in a unidirectional manner [12, 24–26, 45].
To date, this is the first study to examine whether
HRQOLphysical can independently contribute to HRV
in a well-defined healthy population. Our study is also
pioneering in raising the possibility that the relation-
ship between ANS activity and HRQOL could be
Table 3 Hierarchical regression analyses of mean RR intervals and all indices of heart rate variability
Mean RR intervals Var VLF LF HF Ratio
Standardized regression coefficient and p-value
β p β p β p β p β p β p
Step 1 Gender - - 0.03 0.60 0.03 0.56 0.09 0.08 0.02 0.71 - -
Age - - −0.40 <.001 −0.36 <.001 −0.34 <.001 −0.45 <.001 0.14 0.01
Physical activity - - 0.14 0.004 0.12 0.02 0.16 0.001 0.10 0.04 - -
Alcohol use - - - - - - −0.10 0.04 - - −0.12 0.03
BDI −0.11 0.04 −0.20 <.001 −0.20 <.001 - - −0.21 <.001 0.15 0.006
BAI - - −0.21 <.001 −0.13 0.008 −0.20 <.001 −0.15 0.002 - -
R2 1.2 % 27.4 % 20.9 % 24.4 % 27.9 % 5.5 %
Step 2 Gender - - 0.02 0.68 0.03 0.63 0.09 0.09 0.02 0.75 - -
Age - - −0.35 <.001 −0.31 <.001 −0.31 <.001 −0.42 <.001 0.14 0.01
Physical activity - - 0.11 0.02 0.10 0.04 0.14 0.003 0.09 0.07 - -
Alcohol use - - - - - - −0.10 0.04 - - −0.12 0.03
BDI −0.11 0.06 −0.18 <.001 −0.18 <.001 - - −0.20 <.001 0.15 0.006
BAI - - −0.18 <.001 −0.11 0.03 −0.18 <.001 −0.13 0.006 - -
WHOQOL-BREF
physical health domain
0.08 0.17 0.23 <.001 0.21 <.001 0.16 0.002 0.11 0.03 0.06 0.27
R2-changes 0.6 % 4.8 % 3.9 % 2.3 % 1.0 % 0.3 %
F 1.93 22.92 16.53 10.06 4.72 1.12
p value 0.17 <.001 <.001 0.002 0.03 0.27
Abbreviations: Var total variance [ln(ms2)], VLF very low-frequency power [ln(ms2)], LF low frequency power [ln(ms2)], HF high frequency power [ln(ms2)], LF/HF,
ratio of LF to HF [ln(ratio)], BDI Beck Depression Inventory, BAI Beck Anxiety Inventory, WHOQOL-BREF World Health Organization Questionnaire on Quality of Life:
Short Form- Taiwan version
Table 4 Characteristic differences between participants with high scores in the physical domain of QOL and low scores in the
physical domain of QOL







Female sex (%) 48 (26.40) 134 (73.60) 0.03
Age, mean ± SD, years 33.51 ± 10.64 38.44 ± 11.37 <0.001
BMI, mean ± SD, kg/m2 21.83 ± 2.64 21.91 ± 2.36 0.81
Weekly regular exercise, hours 1.82 ± 2.49 1.02 ± 1.97 0.005
Alcohol use, drinks/day 0.01 ± 0.02 0.01 ± 0.02 0.47
SBP, mmHg 115.16 ± 12.46 116.25 ± 12.97 0.48
DBP, mmHg 72.46 ± 7.26 72.84 ± 7.16 0.66
BDI scores, mean ± SD 4.82 ± 3.65 5.89 ± 3.70 0.02
BAI scores, mean ± SD 7.14 ± 2.89 8.17 ± 2.60 0.001
SD standard deviation, BMI body mass index (calculated as weight in kilograms divided by height in meters squared), SBP systolic blood pressure, DBP diastolic
blood pressure, BDI Beck Depression Inventory, BAI Beck Anxiety Inventory
D1, physical domain of WHOQOL-BREF
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bidirectional. The main results of our study are summed
up as follows.
Our study showed a significant contribution of
HRQOLphysical to variances in HRV after excluding po-
tential confounding factors. Consistent with this, when
our participants were divided into two groups by their
scores of HRQOLphysical, those with low HRQOLphysical
exhibited significantly lower HRV as compared with
those with high HRQOLphysical. The significant differ-
ences were not due to the levels of self-reported depres-
sion and/or anxiety because adjusting for psychological
states did not alter the significance. Moreover, it should
be stressed that the difference in the mean BAI scores
between high and low HRQOLphysical groups may be
statistically significant due to a large sample size, but
not be clinically significant because mean BAI scores
of both groups are only within the borderline of min-
imal to mild level of anxiety (score 7–8). The same
applied to the mean BDI scores. In the present study,
the HRQOLphysical includes seven items that comprise
the extent of physical pain, discomfort, energy, fa-
tigue, and quality of sleep. The association of low
HRQOLphysical scores on HRV may be driven by the
overall contributions of the impact of each item on
HRV since data in the literature indicated that com-
pared to healthy controls individuals with low energy
expenditure [46, 47], sleep disturbance [48], chronic
fatigue [17], or chronic pain [49] were associated with
low HRV. A working conceptual model conceptualizes
HRV as a process involving regulatory mechanisms of
ANS, which may structurally, as well as functionally,
link psychological and/or cognitive processes with
health-related physiology [50]. Our study results lend fur-
ther support to this model and suggest that in a healthy
population HRQOLphysical may be a sensitive reflection of
one’s current autonomic balance or a proxy for a subclin-
ical state or disease that are not clinically manifested
yet–– it can be a measure of one’s awareness of the symp-
toms or disease risk factors that may impact upon his or
her future health outcomes especially when these factors
sustained over a long period of time.
It is well known that eighty percent of CVD risk could
be explained by traditional CVD risk factors including
non-modifiable (i.e., age and sex) and modifiable (i.e.,
hypertension, smoking, diabetes, obesity and high chol-
esterol) ones [51, 52]. Little is known about the major
determinants for the remaining twenty percent of risk in
CVD. Researchers have identified reduced HRV [21, 53]
and other nontraditional cardiovascular risk factors
[54, 55] as pointers in helping to improve risk assess-
ment. Recent studies reported that HRQOLphysical was
strongly associated with cardiovascular events and
CVD-specific death, and that the association was in-
dependent of traditional risk factors [56, 57]. One
possibility is that the items of HRQOLphysical mainly
reflect the bodily physiological health determined by
other factors unmeasured in the aforementioned trad-
itional risk calculations but perceived by individuals
[8]. Another possibility is that the sum expression of
the diverse items of HRQOLphysical is conceptually
close to self-rated health (SRH), a simple measure of
subjective health status. Much evidence already shows
that SRH is an independent predictor of CVD incidence
and cardiovascular mortality [58, 59], and that individuals
Fig. 1 Comparison of mean R-R intervals and all measures of HRV between participants with high and low quality of life in the psychological
domain. Values are adjusted for gender, age, physical activity and levels of depression and anxiety. Asterisks indicate significant between-group
differences. Error bars are standard error of the mean
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who assess their health as poor have a higher mortality
risk or cardiovascular events than those whose assessment
is excellent [60]. However, studies in this area did not de-
pict a clear underlying mechanism for HRQOLphysical to
confer increased risk for CVD. Our study results may pro-
vide a new insight on why HRQOLphysical strongly predicts
CVD health and death.
Compared to the strong link observed with HRQOL in
the physical domain and HRV, the associations between
psychological, social, and environmental domain and
HRV were weaker and statistically not significant. This
is consistent with a recent study reporting that these do-
mains did not predict the incidence CV events [8]. This
may be due to the fact that these domains are indirect
indicators that reflect physical health rather than an in-
dependent predictor of autonomic balance. In our study,
the psychological domain includes the extent of positive
and negative feelings, thinking, self-esteem, body image,
and spirit. Some constructs (e.g. pessimism and hope-
lessness) in this domain have been associated with
increased CVD incidence and CVD-specific mortality
[60, 61]. However, most studies have similarly reported a
null association between the mental domain of HRQOL
and CVD outcomes [8, 56]. A possible explanation for the
lack of an association is that WHOQOL-BREF is better at
assessing mental health well-being, and is not designed to
sensitively detect the psychological factors of cardio-
physiologic significance, e.g. depression and anxiety.
Our study clearly demonstrated significant associations
between psychological factors (depress and anxiety) and
HRV in adjusted models (Table 3). Depression and anx-
iety have been related to low HRV among cardiac [62]
and psychiatric patients [15, 16], but this relationships
do not consistently exist among healthy or otherwise un-
selected samples [63–66]. It is conceivable that any asso-
ciations observed in healthy samples may be driven by a
subset of individuals who have not been evaluated for-
mally but nonetheless meet the criteria for mood or anx-
iety disorder. All of our participants were evaluated with
a structured diagnostic interview. This type of screening
ruled out current or past psychiatric disorders. Further-
more, all participants underwent relevant laboratory in-
vestigations in addition to self-reported data of physical
health. Our recent studies have emphasized this object-
ive procedure to exclude subjects with physical co-
morbidities, since subjects might underestimate their
biological risk factors (e.g., elevated glucose and athero-
genic lipid profile) for cardiac autonomic dysregulation
when these factors were self-reported [67]. Overall, our
sample was well suited for studying the relationship
between HRV and the factors investigated, as the effects
of potential confounding factors were minimized. We
believe that the above-mentioned strengths reinforce the
reliability of our results.
The implications of this study’s findings are potentially
important to clinicians and researchers. HRQOL is the
sum expression of diverse influencing factors and is not
easy to determine. Our study provides a clinically helpful
option of identifying a specific HRQOL domain of cardi-
ophysiologic significance and clinical usefulness in car-
diovascular prevention. If replicated, HRQOLphysical may
serve as a valuable screening tool in the healthy adult
population to identify those who are potentially at-risk
for CVD. It may also help identify and/or elaborate
those interventions to lower the incidence of CVD mor-
tality in some people. Specifically, a 5-min HRV analysis
can be done for individuals with a low HRQOLphysical
scores to provide a rapid screening of systemic auto-
nomic disturbance without much burden on them; then
as a next step, those who are found to have low HRV may
benefit from cardiovascular risk reduction strategies.
The main finding of the independent contribution of
HRQOLphysical to explaining variance in HRV was mostly
attributable to the influence that HRQOLphysical has on
the VLF and LF component of spectral HRV (Table 3).
Because the definite physiological meaning of VLF is
under debate, we were unable to accurately interpret the
finding of VLF component; nevertheless, our finding that
individuals with low HRQOLphysical were associated with
lower LF-HRV is of great importance. Some researchers
argue that LF power in supine subjects principally re-
flects baroreflex sensitivity, which is a measure of the
gain of the baroreflex [43, 68]. The arterial baroreflex is
the main mediator of HRV [69]. Therefore, it is possible
that low HRQOLphysical contributes to lower baroreflex
functioning, which in turn leads to reduced HRV.
The present study has two limitations. First, causality
cannot be inferred from our cross-sectional data. Sec-
ond, the presented regression analyses in our study re-
vealed several statistically significant associations but the
level of correlation (or regression coefficient) was low
and insofar may be not physiologically relevant. The
exploratory information about possible relations pro-
vided by our results requires further confirmation. Sec-
ond, we classified the healthy individuals into high or
low HRQOLphysical groups according to only the quar-
tiles of the sample HRQOLphysical scores. The optimum
HRQOLphysical scores to dichotomize healthy adults and
to produce the largest contribution of a prognostic pre-
dictor to the physiologically relevant reduction in HRV
should be explored in future research.
Conclusions
This study highlights the possible role of HRQOLphysical
in independently contributing to the variances in HRV
of asymptomatic healthy adults, and provides a new
insight of the linkage between HRQOLphysical and car-
diovascular risk.
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